Efficacy of Interval Aerobic Training Versus Laser Puncture Therapy on Restless Leg Syndrome in Copd Patient
1 other identifier
interventional
60
1 country
1
Brief Summary
DETERMINE HOW TO IMPROVE THE QUALITY OF LIFE FOR PATIENTS WITH COPD BY DECREASING TINTENSITY OF THE RESTLESS SYNDROME
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable chronic-obstructive-pulmonary-disease
Started May 2025
Shorter than P25 for not_applicable chronic-obstructive-pulmonary-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2025
CompletedFirst Posted
Study publicly available on registry
May 2, 2025
CompletedStudy Start
First participant enrolled
May 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 5, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 25, 2025
CompletedMay 2, 2025
April 1, 2025
1 month
April 24, 2025
April 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Restless Legs Syndrome Rating Scale (IRLS):
Developed as a tool for assessing the severity Restless Legs Syndrome (RLS), the 10-item questionnaire asks respondents to use Likert-type ratings to indicate how acutely the disorder has affected them over the course of the past week. Questions can be divided into one of two catego- ries: disorder symptoms (nature, intensity, and frequency) and their impact (sleep issues, distur- bances in daily functioning, and resultant changes in mood)
3 month
Fatigue severity scale (FSS):
The FSS is a short questionnaire that requires you to rate your level of fatigue. The FSS questionnaire contains nine statements that rate the severity of your fatigue symptoms. Read each statement and circle a number from 1 to 7, based on how accurately it reflects your condition during the past week and the extent to which you agree or disagree that the statement applies to you
3 month
Six mint walk test:
the 6-minute walk test (6MWT) is a key study providing a functional, therapeutic response, and prognostic data that is valuable in the care of patients with respiratory as well as cardiac diseases. It is used widely due to its simplicity and reproducibility,
3 month
Secondary Outcomes (1)
Hemoglobin Test:
3 month
Study Arms (2)
aerobic training
EXPERIMENTAL3 sessions per week,40 mints each session, mild to moderate intensity exercise
laser puncture therapy
EXPERIMENTALThere were three sessions per week, each lasting 40 minutes. Five minutes later, a laser probe was applied to the acupuncture sites on the leg.
Interventions
Patients in this group were instructed to sit on a stationary bicycle ergometer. The patients will be given explained the aerobic interval exercise training program and the intensity will be assessed using a modified Borg scale
This group's patients were all exposed to LLLT utilising Phyaction CL Phyaction, Bilzen, Belgium, which had the following specs: frequency 500 Hz, output 5-20 MW, wavelength 905 nm. For five minutes, a laser probe was applied to acupuncture sites
Eligibility Criteria
You may qualify if:
- Men with COPD who were between the ages of 40 and 60 and had a BMI between 25.5 and 29.0 were eligible to enroll if they had received a diagnosis of COPD at least two years priorAn intense desire to move the legs is frequently accompanied by unpleasant and uncomfortable leg sensations. Patients usually experience worsening symptoms when they are at rest, sitting, or lying down. Walking and stretching are examples of physical activity that can help reduce these symptoms to some or all of their intensity
You may not qualify if:
- \) Individuals suffering from acute infections and malignant diseases; 2) Individuals with a history of kidney disease, hiatus hernia, severe gastro-esophageal reflux, and osteoporosis 3) Patients with severe anemia and congestive heart failure 4) Individuals with severe neurological and musculoskeletal conditions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ola Mohamed Elsayed Elgohary
Alexandria, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer at cardiovascular pulmonary and geratrics departement faculty of physical therapy pharos university
Study Record Dates
First Submitted
April 24, 2025
First Posted
May 2, 2025
Study Start
May 25, 2025
Primary Completion
July 5, 2025
Study Completion
July 25, 2025
Last Updated
May 2, 2025
Record last verified: 2025-04